Journal article
Amphetamine disrupts haemodynamic correlates of prediction errors in nucleus accumbens and orbitofrontal cortex
- Abstract:
- In an uncertain world, the ability to predict and update the relationships between environmental cues and outcomes is a fundamental element of adaptive behaviour. This type of learning is typically thought to depend on prediction error, the difference between expected and experienced events and in the reward domain that has been closely linked to mesolimbic dopamine. There is also increasing behavioural and neuroimaging evidence that disruption to this process may be a cross-diagnostic feature of several neuropsychiatric and neurological disorders in which dopamine is dysregulated. However, the precise relationship between haemodynamic measures, dopamine and reward-guided learning remains unclear. To help address this issue, we used a translational technique, oxygen amperometry, to record haemodynamic signals in the nucleus accumbens (NAc) and orbitofrontal cortex (OFC), while freely moving rats performed a probabilistic Pavlovian learning task. Using a model-based analysis approach to account for individual variations in learning, we found that the oxygen signal in the NAc correlated with a reward prediction error, whereas in the OFC it correlated with an unsigned prediction error or salience signal. Furthermore, an acute dose of amphetamine, creating a hyperdopaminergic state, disrupted rats’ ability to discriminate between cues associated with either a high or a low probability of reward and concomitantly corrupted prediction error signalling. These results demonstrate parallel but distinct prediction error signals in NAc and OFC during learning, both of which are affected by psychostimulant administration. Furthermore, they establish the viability of tracking and manipulating haemodynamic signatures of reward-guided learning observed in human fMRI studies by using a proxy signal for BOLD in a freely behaving rodent.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Corrected version of record, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41386-019-0564-8
Authors
+ Wellcome Trust
More from this funder
- Funding agency for:
- Walton, ME
- Grant:
- Senior Research Fellowship: 202831/Z/16/Z
+ Lilly Research Award
More from this funder
- Funding agency for:
- Walton, ME
- Grant:
- Senior Research Fellowship: 202831/Z/16/Z
- Publisher:
- Springer Nature
- Journal:
- Neuropsychopharmacology More from this journal
- Volume:
- 45
- Pages:
- 793–803
- Publication date:
- 2019-11-08
- Acceptance date:
- 2019-10-29
- DOI:
- EISSN:
-
1740-634X
- ISSN:
-
0893-133X
- Keywords:
- Pubs id:
-
pubs:1068641
- UUID:
-
uuid:bb5df560-6bfe-4b66-ae90-d2c1ad7a88f4
- Local pid:
-
pubs:1068641
- Source identifiers:
-
1068641
- Deposit date:
-
2019-10-30
Terms of use
- Copyright holder:
- Werlen et al
- Copyright date:
- 2019
- Notes:
-
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record